Nihanthy Sreenath, Consultant of Medical Oncology and Hemato-Oncology at Saroj Gupta Cancer Centre and Research Institute, shared a post on LinkedIn:
“Delighted to share our brief commentary on KEYNOTE-564, highlighting its impact on adjuvant immunotherapy in renal cell carcinoma.
Grateful for the opportunity to add to this important conversation in oncology.”
More posts featuring KEYNOTE-564.
